Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schildknecht

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
ALTEX|January 16, 2025
The long way from raw data to NAM-based information: Overview on data layers and processing stepsJonathan Blum, Markus Brüll, Jan G Hengstler, et al.
NPJ Precision Oncology|June 29, 2026
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysisMarie-Elisabeth Leßmann, Felix Carl Saalfeld, Lea Ruge, et al.
MMWR. Morbidity and Mortality Weekly Report|January 4, 2024
Second Nationwide Tuberculosis Outbreak Caused by Bone Allografts Containing Live Cells - United States, 2023Jonathan M Wortham, Maryam B Haddad, Rebekah J Stewart, et al.
Archives of Toxicology|October 21, 2017
Adverse outcome pathways: opportunities, limitations and open questionsMarcel Leist, Ahmed Ghallab, Rabea Graepel, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
ALTEX|January 16, 2025
The long way from raw data to NAM-based information: Overview on data layers and processing stepsJonathan Blum, Markus Brüll, Jan G Hengstler, et al.
NPJ Precision Oncology|June 29, 2026
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysisMarie-Elisabeth Leßmann, Felix Carl Saalfeld, Lea Ruge, et al.
MMWR. Morbidity and Mortality Weekly Report|January 4, 2024
Second Nationwide Tuberculosis Outbreak Caused by Bone Allografts Containing Live Cells - United States, 2023Jonathan M Wortham, Maryam B Haddad, Rebekah J Stewart, et al.
Archives of Toxicology|October 21, 2017
Adverse outcome pathways: opportunities, limitations and open questionsMarcel Leist, Ahmed Ghallab, Rabea Graepel, et al.
Pageof 18